(NASDAQ: ASPI) Asp Isotopes's forecast annual revenue growth rate of 238.64% is forecast to beat the US Chemicals industry's average forecast revenue growth rate of 2.43%, and it is also forecast to beat the US market's average forecast revenue growth rate of 22.74%.
Asp Isotopes's revenue in 2025 is $8,383,354.On average, 5 Wall Street analysts forecast ASPI's revenue for 2026 to be $4,674,460,465, with the lowest ASPI revenue forecast at $3,475,946,226, and the highest ASPI revenue forecast at $5,823,429,170. On average, 5 Wall Street analysts forecast ASPI's revenue for 2027 to be $10,560,181,783, with the lowest ASPI revenue forecast at $8,689,865,565, and the highest ASPI revenue forecast at $12,821,985,313.
In 2028, ASPI is forecast to generate $42,631,327,724 in revenue, with the lowest revenue forecast at $40,959,858,684 and the highest revenue forecast at $43,886,037,905.